세계의 맞춤형 의료 바이오마커 시장 보고서(2025년)

Personalized medicine biomarkers are specific biological indicators that customize medical treatments for individual patients based on their unique genetic, molecular, or physiological characteristics. These biomarkers help predict how a patient will respond to a particular drug, allowing healthcare providers to select the most effective and safest treatment options.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The main types of biomarkers in personalized medicine include genomic, proteomic, metabolic, and other types. Genomic biomarkers refer to specific genes or genetic mutations that provide insights into how diseases develop and progress in individuals. These biomarkers are used for a variety of disease indications, such as oncology, neurology, diabetes, autoimmune diseases, cardiology, and more. They serve various purposes, including early detection or screening, diagnosis, treatment selection, and monitoring. Personalized medicine biomarkers are utilized by a range of end users, including hospitals and clinics, pharmaceutical and biotechnology companies, diagnostic laboratories, and others.

The personalized medicine biomarkers market research report is one of a series of new reports from The Business Research Company that provides personalized medicine biomarkers market statistics, including personalized medicine biomarkers industry global market size, regional shares, competitors with a personalized medicine biomarkers market share, detailed personalized medicine biomarkers market segments, market trends and opportunities, and any further data you may need to thrive in the personalized medicine biomarkers industry. This personalized medicine biomarkers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The personalized medicine biomarkers market size has grown rapidly in recent years. It will grow from $22.85 billion in 2024 to $26.98 billion in 2025 at a compound annual growth rate (CAGR) of 18.0%. The growth during the historic period can be attributed to the increasing prevalence of chronic diseases, the rising adoption of companion diagnostics, growing investment in biomarker research, a heightened focus on early diagnosis and preventive healthcare, and regulatory support for biomarker-based therapies.

The personalized medicine biomarkers market size is expected to see rapid growth in the next few years. It will grow to $51.53 billion in 2029 at a compound annual growth rate (CAGR) of 17.6%. The growth during the forecast period can be attributed to the expanding applications of biomarkers in precision oncology, rising demand for targeted therapies, a growing focus on early disease detection, increasing consumer demand for personalized approaches, and supportive government policies and funding. Key trends expected in the forecast period include the adoption of a multi-omics approach for biomarker identification, the development of liquid biopsy-based biomarkers, a growing use of digital biomarkers, the integration of AI and machine learning in biomarker discovery, and the expansion of real-world evidence in biomarker validation.

The growing prevalence of chronic diseases is expected to drive substantial growth in the personalized medicine biomarkers market. Chronic diseases are long-term conditions that develop gradually and persist for extended periods, often requiring ongoing medical care or affecting daily activities. The rise in chronic diseases is largely attributed to unhealthy lifestyle choices, poor diets, insufficient physical activity, and high stress levels. Personalized medicine biomarkers play a key role in managing these conditions by tailoring treatments based on individual genetic and molecular profiles. These biomarkers help identify the most effective therapies, predict disease progression, and minimize adverse effects. For example, the World Health Organization (WHO) predicts that by 2050, the number of new cancer cases will exceed 35 million, a 77% increase from 2022. This escalating prevalence of chronic diseases is accelerating demand for personalized medicine biomarkers.

Companies in the personalized medicine biomarkers market are focusing on obtaining regulatory approvals to enhance product credibility, expand their market reach, and improve patient outcomes. Regulatory approvals are essential as they ensure that medical products, treatments, or technologies meet safety, efficacy, and quality standards. For instance, in August 2024, Illumina, Inc., a US-based biotechnology company, received FDA approval for its cancer biomarker test and two companion diagnostics. The test uses next-generation sequencing (NGS) technology to identify genetic mutations in cancer cells, allowing clinicians to select the most appropriate treatments based on individual biomarkers. This approval represents a significant milestone in precision oncology, improving the speed and accuracy of treatment selection and enhancing personalized care for cancer patients.

In February 2025, Renovaro Inc., a US-based biotechnology firm, merged with BioSymetrics Inc. to boost AI-driven biomarker discovery and precision medicine initiatives. The merger is set to enhance drug development and facilitate the creation of personalized treatment strategies, particularly for complex diseases. BioSymetrics Inc., a Canada-based company specializing in phenomics-driven drug discovery, uses machine learning to integrate clinical and experimental data, advancing the field of precision medicine.

Major players in the personalized medicine biomarkers market are AbbVie Inc., Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Abbott Laboratories, Novartis AG, Merck KGaA, GE Healthcare, Laboratory Corporation of America Holdings (LabCorp), Agilent Technologies Inc., Hologic Inc., Illumina Inc., PerkinElmer Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., DH Life Sciences LLC, Myriad Genetics Inc., Guardant Health Inc., Cardiff Oncology Inc., 23andMe Inc., Coriell Life Sciences Inc.

North America was the largest region in the personalized medicine biomarkers market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in personalized medicine biomarkers report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the personalized medicine biomarkers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The personalized medicine biomarkers market consists of sales of biomarker-based diagnostic kits, reagents, testing platforms, epigenetic biomarkers, companion diagnostics, predictive biomarkers, prognostic biomarkers, and multi-omics biomarkers. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Personalized Medicine Biomarkers Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on personalized medicine biomarkers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for personalized medicine biomarkers ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The personalized medicine biomarkers market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Biomarker Type: Genomic; Proteomics; Metabolic; Other Biomarker Types
• 2) By Disease Indication: Oncology; Neurology; Diabetes; Autoimmune Diseases; Cardiology; Other Indications
• 3) By Application: Early Detection Or Screening; Diagnosis; Treatment Selection; Monitoring
• 4) By End Use: Hospitals And Clinics; Pharmaceutical And Biotechnology Companies; Diagnostic Labs; Other End Users
• Subsegments:
• 1) By Genomic: Single Nucleotide Polymorphisms (SNPs); Copy Number Variations (CNVs); Gene Expression Biomarkers; Epigenetic Biomarkers
• 2) By Proteomics: Protein Expression Biomarkers; Post-Translational Modification (PTM) Biomarkers; Protein-Protein Interaction Biomarkers; Enzyme Activity Biomarkers
• 3) By Metabolic: Lipid Biomarkers; Amino Acid Biomarkers; Carbohydrate Biomarkers; Hormone Biomarkers
• 4) By Other Biomarker Types: Inflammatory Biomarkers; Microbiome Biomarkers; Autoantibody Biomarkers; Extracellular Vesicle Biomarkers
• Companies Mentioned: AbbVie Inc.; Bristol-Myers Squibb Company; Thermo Fisher Scientific Inc.; Abbott Laboratories; Novartis AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Personalized Medicine Biomarkers Market Characteristics

3. Personalized Medicine Biomarkers Market Trends And Strategies

4. Personalized Medicine Biomarkers Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Personalized Medicine Biomarkers Growth Analysis And Strategic Analysis Framework

• 5.1. Global Personalized Medicine Biomarkers PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Personalized Medicine Biomarkers Market Growth Rate Analysis
• 5.4. Global Personalized Medicine Biomarkers Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Personalized Medicine Biomarkers Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Personalized Medicine Biomarkers Total Addressable Market (TAM)

6. Personalized Medicine Biomarkers Market Segmentation

• 6.1. Global Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Genomic
• Proteomics
• Metabolic
• Other Biomarker Types
• 6.2. Global Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oncology
• Neurology
• Diabetes
• Autoimmune Diseases
• Cardiology
• Other Indications
• 6.3. Global Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Early Detection Or Screening
• Diagnosis
• Treatment Selection
• Monitoring
• 6.4. Global Personalized Medicine Biomarkers Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Clinics
• Pharmaceutical And Biotechnology Companies
• Diagnostic Labs
• Other End Users
• 6.5. Global Personalized Medicine Biomarkers Market, Sub-Segmentation Of Genomic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Single Nucleotide Polymorphisms (SNPs)
• Copy Number Variations (CNVs)
• Gene Expression Biomarkers
• Epigenetic Biomarkers
• 6.6. Global Personalized Medicine Biomarkers Market, Sub-Segmentation Of Proteomics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Protein Expression Biomarkers
• Post-Translational Modification (PTM) Biomarkers
• Protein-Protein Interaction Biomarkers
• Enzyme Activity Biomarkers
• 6.7. Global Personalized Medicine Biomarkers Market, Sub-Segmentation Of Metabolic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Lipid Biomarkers
• Amino Acid Biomarkers
• Carbohydrate Biomarkers
• Hormone Biomarkers
• 6.8. Global Personalized Medicine Biomarkers Market, Sub-Segmentation Of Other Biomarker Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Inflammatory Biomarkers
• Microbiome Biomarkers
• Autoantibody Biomarkers
• Extracellular Vesicle Biomarkers

7. Personalized Medicine Biomarkers Market Regional And Country Analysis

• 7.1. Global Personalized Medicine Biomarkers Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Personalized Medicine Biomarkers Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Personalized Medicine Biomarkers Market

• 8.1. Asia-Pacific Personalized Medicine Biomarkers Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Personalized Medicine Biomarkers Market

• 9.1. China Personalized Medicine Biomarkers Market Overview
• 9.2. China Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Personalized Medicine Biomarkers Market

• 10.1. India Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Personalized Medicine Biomarkers Market

• 11.1. Japan Personalized Medicine Biomarkers Market Overview
• 11.2. Japan Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Personalized Medicine Biomarkers Market

• 12.1. Australia Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Personalized Medicine Biomarkers Market

• 13.1. Indonesia Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Personalized Medicine Biomarkers Market

• 14.1. South Korea Personalized Medicine Biomarkers Market Overview
• 14.2. South Korea Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Personalized Medicine Biomarkers Market

• 15.1. Western Europe Personalized Medicine Biomarkers Market Overview
• 15.2. Western Europe Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Personalized Medicine Biomarkers Market

• 16.1. UK Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Personalized Medicine Biomarkers Market

• 17.1. Germany Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Personalized Medicine Biomarkers Market

• 18.1. France Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Personalized Medicine Biomarkers Market

• 19.1. Italy Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Personalized Medicine Biomarkers Market

• 20.1. Spain Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Personalized Medicine Biomarkers Market

• 21.1. Eastern Europe Personalized Medicine Biomarkers Market Overview
• 21.2. Eastern Europe Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Personalized Medicine Biomarkers Market

• 22.1. Russia Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Personalized Medicine Biomarkers Market

• 23.1. North America Personalized Medicine Biomarkers Market Overview
• 23.2. North America Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Personalized Medicine Biomarkers Market

• 24.1. USA Personalized Medicine Biomarkers Market Overview
• 24.2. USA Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Personalized Medicine Biomarkers Market

• 25.1. Canada Personalized Medicine Biomarkers Market Overview
• 25.2. Canada Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Personalized Medicine Biomarkers Market

• 26.1. South America Personalized Medicine Biomarkers Market Overview
• 26.2. South America Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Personalized Medicine Biomarkers Market

• 27.1. Brazil Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Personalized Medicine Biomarkers Market

• 28.1. Middle East Personalized Medicine Biomarkers Market Overview
• 28.2. Middle East Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Personalized Medicine Biomarkers Market

• 29.1. Africa Personalized Medicine Biomarkers Market Overview
• 29.2. Africa Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Personalized Medicine Biomarkers Market Competitive Landscape And Company Profiles

• 30.1. Personalized Medicine Biomarkers Market Competitive Landscape
• 30.2. Personalized Medicine Biomarkers Market Company Profiles
  • 30.2.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

31. Personalized Medicine Biomarkers Market Other Major And Innovative Companies

• 31.1. Merck KGaA
• 31.2. GE Healthcare
• 31.3. Laboratory Corporation of America Holdings (LabCorp)
• 31.4. Agilent Technologies Inc.
• 31.5. Hologic Inc.
• 31.6. Illumina Inc.
• 31.7. PerkinElmer Inc.
• 31.8. Beckman Coulter Inc.
• 31.9. Bio-Rad Laboratories Inc.
• 31.10. QIAGEN N.V.
• 31.11. DH Life Sciences LLC
• 31.12. Myriad Genetics Inc.
• 31.13. Guardant Health Inc.
• 31.14. Cardiff Oncology Inc.
• 31.15. 23andMe Inc.

32. Global Personalized Medicine Biomarkers Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Personalized Medicine Biomarkers Market

34. Recent Developments In The Personalized Medicine Biomarkers Market

35. Personalized Medicine Biomarkers Market High Potential Countries, Segments and Strategies

• 35.1 Personalized Medicine Biomarkers Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Personalized Medicine Biomarkers Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Personalized Medicine Biomarkers Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer
• 250617_r34923_Personalized_Medicine_Biomarkers_GMR_2025